Highlights from the April 2022 Issue
Editor’s Note: We asked authors of Original Investigations to provide short plain-language summaries that would briefly summarize what inspired their study, the basic [...]
ADPKD
Renal Ciliopathies: A Pediatric Nephrology Perspective
The non-motile primary cilium, a specialized organelle found in nucleated mammalian cells, plays an important role in human biology due to its pleiotropic effects. This [...]
#NephMadness 2020 The Impact of Genetic Testing on A Person: A Patient Perspective
@KidneyRebel is a patient with ADPKD who wishes to remain anonymous at this time for personal reasons. They are a staunch advocate for progress and innovation in nephrology [...]
Clinical Trial End Points in ADPKD
Despite our current understanding regarding the pathophysiology of autosomal dominant polycystic kidney disease (ADPKD), only one therapy has been approved by the US FDA. [...]
Predicting Polyuria: Can We Help Patients with ADPKD Better Tolerate Tolvaptan?
Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited kidney disease, often results in the need for renal replacement therapy, and is the etiology [...]
Advancing Patient-Centered Care in Autosomal Dominant Polycystic Kidney Disease
In a recent study published in AJKD, Oberdhan et al (Open Access) discuss the development of a new health-related quality of life (HRQoL) tool for patients with Autosomal [...]